Szilárd Rezes1, Katalin Késmárki, Sándor Sipka, István Sziklai. 1. Department of Otorhinolaryngology/Head and Neck Surgery, and Autoimmune Research Group of the Hungarian Academy of Sciences, Health Science Center, University of Debrecen, Debrecen, Hungary. szrezes@freemail.hu
Abstract
OBJECTIVE: To characterize the groups of middle ear effusions (MEE) defined on the basis of the ratio of albumin and immunoglobulin G concentrations (A/G) in the effusion and to identify the correlation between these groups of MEE and the clinical features of otitis media with effusion (OME). STUDY DESIGN: A laboratory analysis of 88 samples of MEE and a retrospective analysis of the medical history of all patients was performed. SETTING: Tertiary referral center. PATIENTS: Thirty-three girls and 23 boys with OME were included in the study. INTERVENTION: The concentrations of albumin, immunoglobulins (IgG, IgA, and IgM), complement factors (C3, C4), and C-reactive protein were determined by means of nephelometry. Enzyme-linked immunosorbent assay was used to measure cytokines interferon-gamma, tumor necrosis factor alpha, interleukin (IL)-4, and IL-10 concentrations. Groups were defined according to A/G ratio in the effusions. Thirty-five children underwent allergy testing. MAIN OUTCOME MEASURE: Two groups of MEE could be recognized on the basis of A/G ratio; the ratio was lower than 0.7 in group A and was higher than 0.7 in group B. RESULTS: Increased levels of interferon-gamma and tumor necrosis factor alpha were observed in group A, whereas IL-4 and IL-10 were dominating in group B. No association was found between the MEE groups and the clinical features of the disease or the atopic status of the patient. CONCLUSION: These results suggest that various groups of OME can be categorized according to the differences in A/G ratio in the effusions. These differences can reflect the variances in the pathomechanism of the development of the effusion, the stage of the disease, or the clinical background of the patients.
OBJECTIVE: To characterize the groups of middle ear effusions (MEE) defined on the basis of the ratio of albumin and immunoglobulin G concentrations (A/G) in the effusion and to identify the correlation between these groups of MEE and the clinical features of otitis media with effusion (OME). STUDY DESIGN: A laboratory analysis of 88 samples of MEE and a retrospective analysis of the medical history of all patients was performed. SETTING: Tertiary referral center. PATIENTS: Thirty-three girls and 23 boys with OME were included in the study. INTERVENTION: The concentrations of albumin, immunoglobulins (IgG, IgA, and IgM), complement factors (C3, C4), and C-reactive protein were determined by means of nephelometry. Enzyme-linked immunosorbent assay was used to measure cytokines interferon-gamma, tumor necrosis factor alpha, interleukin (IL)-4, and IL-10 concentrations. Groups were defined according to A/G ratio in the effusions. Thirty-five children underwent allergy testing. MAIN OUTCOME MEASURE: Two groups of MEE could be recognized on the basis of A/G ratio; the ratio was lower than 0.7 in group A and was higher than 0.7 in group B. RESULTS: Increased levels of interferon-gamma and tumor necrosis factor alpha were observed in group A, whereas IL-4 and IL-10 were dominating in group B. No association was found between the MEE groups and the clinical features of the disease or the atopic status of the patient. CONCLUSION: These results suggest that various groups of OME can be categorized according to the differences in A/G ratio in the effusions. These differences can reflect the variances in the pathomechanism of the development of the effusion, the stage of the disease, or the clinical background of the patients.
Authors: Carmen Puig; Sara Marti; Peter W M Hermans; Marien I de Jonge; Carmen Ardanuy; Josefina Liñares; Jeroen D Langereis Journal: Infect Immun Date: 2014-01-22 Impact factor: 3.441
Authors: Michael T Cheeseman; Hayley E Tyrer; Debbie Williams; Tertius A Hough; Paras Pathak; Maria R Romero; Helen Hilton; Sulzhan Bali; Andrew Parker; Lucie Vizor; Tom Purnell; Kate Vowell; Sara Wells; Mahmood F Bhutta; Paul K Potter; Steve D M Brown Journal: PLoS Genet Date: 2011-10-20 Impact factor: 5.917
Authors: Jeroen D Langereis; Kim Stol; Elke K Schweda; Brigitte Twelkmeyer; Hester J Bootsma; Stefan P W de Vries; Peter Burghout; Dimitri A Diavatopoulos; Peter W M Hermans Journal: MBio Date: 2012-07-03 Impact factor: 7.867
Authors: Anita Szalmás; Zoltán Papp; Péter Csomor; József Kónya; István Sziklai; Zoltán Szekanecz; Tamás Karosi Journal: Biomed Res Int Date: 2013-09-23 Impact factor: 3.411
Authors: Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang Journal: Clin Exp Otorhinolaryngol Date: 2008-09-30 Impact factor: 3.372